首页> 外文期刊>Journal of otolaryngology - head & neck surgery = >Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis
【24h】

Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis

机译:215例腮腺肿瘤患者的结果分析:回顾性队列分析

获取原文
           

摘要

Background To identify prognostic factors in patients with parotid gland carcinomas who were treated at the Princess Margaret Hospital. Methods Clinical outcome of two hundred fifteen patients with malignancies of the parotid gland was evaluated over a 16-year period. Results Two-hundred-fifteen patients with adenoid cystic carcinoma (n?=?20), adenocarcinoma (n?=?19), acinic cell carcinoma (n?=?62), basal cell adenocarcinoma (n?=?7), carcinoma-ex-pleomorphic adenoma (n?=?18), mucoepidermoid carcinoma (n?=?70) and salivary duct carcinoma (n?=?19) have been included. The 5- and 10-year overall and disease-free survivals were 80.62?%/69.48?% and 74.37?%/62.42?%, respectively. Multivariable analysis showed that age greater than 60?years, advanced pN classification, histopathological grade and the presence of lymphovascular invasion significantly worsened overall and disease-free survival. Univariable analysis revealed periparotid lymph node involvement was associated with decreased overall (p?p? Conclusions In addition to age, pN classification, histopathological grade, perineural invasion, and lymphovascular involvement, periparotid lymph node metastasis appears to be an important prognosticator in parotid gland malignancy.
机译:背景为了确定玛格丽特公主医院接受治疗的腮腺癌患者的预后因素。方法评估16年来115例腮腺恶性肿瘤的临床结果。结果255例腺样囊性癌(n = 20),腺癌(n = 19),腺癌(n = 62),基底细胞腺癌(n = 7),包括癌-多形性腺瘤(n≥18),粘液表皮样癌(n≥70)和唾液管癌(n≥19)。 5年和10年总生存率和无病生存率分别为80.62%/ 69.48%和74.37%/ 62.42%。多变量分析表明,年龄大于60岁,pN分类晚期,组织病理学分级以及淋巴管浸润的存在显着恶化了总体生存率和无病生存期。单变量分析显示,腮腺周围淋巴结受累与总体下降相关(p?p?结论)除年龄,pN分类,组织病理学分级,神经周浸润和淋巴管受累外,腮腺周围淋巴结转移似乎是腮腺恶性肿瘤的重要预后指标。 。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号